On June 6, 2017, DevicePharm was honored to make the opening presentation at the 2017 Spring BioBash in Austin, Texas. The presentation was titled, “So You’re Going To Launch”. It was presented to provide a guide for med-tech executives, marketers, and entrepreneurs who are launching new products, companies, and markets.
Category Archives: Healthcare Marketing Strategies
DevicePharm, a marketing strategy and integrated marketing solutions firm, was awarded two 2016 International Davey Awards this month for work created on behalf of Bausch + Lomb’s VICTUS® Femtosecond Laser Platform brand and Clarity Medical’s HOLOS IntraOp™ brand.
SkylineDx debuted its new MMprofiler™ with SKY92 campaign this year during the European Hematology Association conference in Denmark. MMprofiler with SKY92 enables physicians to quickly and confidently identify high-risk multiple myeloma patients.
UK Trade & Investment — the business development arm of the British Consulate — invited DevicePharm CEO & Chief Strategy Officer, Clay Wilemon, to present to UK medical firms during a February conference.
At the 2015 San Antonio Breast Cancer Symposium, Provista introduced Videssa® Breast, a breakthrough that accurately detects the presence or absence of breast cancer with a protein-based blood test. Videssa® Breast provides clinicians, and their patients, with clinical confidence, clarity and peace-of-mind about what to do next when mammography is unclear – detecting the absence or presence of breast cancer by identifying early warning signals called biomarkers.
The mindset a few years ago for website development was to consider how a digital property was going to look on a mobile device. As responsive design became a reality, the logic shifted to one focused on providing a quality mobile user experience . Now, with mobile usage far surpassing computer usage for initial searches, we have to have a mobile optimized mindset as we create content for healthcare professionals.
What if you could focus your marketing plans and messaging only on the people who were actually going to buy your product or service?” This was the question posed by Clay Wilemon, DevicePharm CEO & Chief Strategy Officer, to an enthusiastic audience in San Diego during the September Device Alliance meeting.
The reality is that using predictive analytics in market research is providing a more precise way of targeting, messaging, and selling to the customers who are actually going to buy your products.
The U.S. Government states that the Affordable Care Act has three main objectives. And while these are very nice, laudable, and simple goals, they are creating paradigm shifts in the marketing and selling of medical devices.
Imagine looking at market research results and seeing that a large population of consumers wanted to pay a relatively low price for a new elective medical procedure. Just a few years ago, this would have been a cut-and-dry result leading to a lower price. However, using an advanced predictive analytics platform powered by Compellon, DevicePharm was able to dig deeper and determine that the actionable market was actually bigger with the higher price point.
“Do we really need sales reps to support medical devices?” This question has been asked by surgeons, medical device CEOs, and hospital administrators for years. Recently, however, that philosophical question moved from theory to practice in a bold move by Smith & Nephew.